KAM
Kazazian Asset Management Portfolio holdings
AUM
$82.9M
1-Year Est. Return
52.64%
1 Year Est. Return
+52.64%
AUM
$72.4M
AUM Growth
-$49.6M
(-41%)
Holding
62
Top Buys
| 1 | +$1.28M | |
| 2 | +$722K | |
| 3 | +$395K | |
| 4 |
CRWV
CoreWeave Inc
CRWV
|
+$277K |
| 5 |
Sarepta Therapeutics
SRPT
|
+$257K |
Top Sells
| 1 | +$13.7M | |
| 2 | +$12.5M | |
| 3 | +$10.1M | |
| 4 |
Alibaba
BABA
|
+$5.22M |
| 5 |
Chewy
CHWY
|
+$4.05M |
Sector Composition
| 1 | Communication Services | 33.44% |
| 2 | Consumer Discretionary | 29.2% |
| 3 | Financials | 19.46% |
| 4 | Technology | 8.32% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
MacroGenics
MGNX
$94.8M
| – | – |
-19,236
|
|
||
52
Madrigal Pharmaceuticals
MDGL
$12B
| – | – |
-955
|
|
||
53
Geron
GERN
$798M
| – | – |
-47,500
|
|
||
54
Exelixis
EXEL
$11.6B
| – | – |
-6,650
|
|
||
55
iShares MSCI Mexico ETF
EWW
$2.06B
| – | – |
-4,168
|
|
||
56
Cytokinetics
CYTK
$8.06B
| – | – |
-9,796
|
|
||
57
BILL Holdings
BILL
$5.19B
| – | – |
-5,272
|
|
||
58
BridgeBio Pharma
BBIO
$12.7B
| – | – |
-11,840
|
|
||
|
AVDL
59
Avadel Pharmaceuticals
AVDL
$1.86B
| – | – |
-106,120
|
|
||
60
Aurinia Pharmaceuticals
AUPH
$2.04B
| – | – |
-10,450
|
|
||
61
argenx
ARGX
$55.3B
| – | – |
-380
|
|
||
62
ALX Oncology
ALXO
$68.9M
| – | – |
-19,000
|
|